O'Brien, P. M., Davies, M. J., Scurry, J. P., Smith, A. N., Barton, C. A., Henderson, M. J., . . . Sutherland, R. L. (2008). The E3 ubiquitin ligase EDD is an adverse prognostic factor for serous epithelial ovarian cancer and modulates cisplatin resistance in vitro. Nature Publishing Group.
Chicago Style CitationO'Brien, P M., et al. The E3 Ubiquitin Ligase EDD Is an Adverse Prognostic Factor for Serous Epithelial Ovarian Cancer and Modulates Cisplatin Resistance in Vitro. Nature Publishing Group, 2008.
Cita MLAO'Brien, P M., et al. The E3 Ubiquitin Ligase EDD Is an Adverse Prognostic Factor for Serous Epithelial Ovarian Cancer and Modulates Cisplatin Resistance in Vitro. Nature Publishing Group, 2008.
Atenció: Aquestes cites poden no estar 100% correctes.